Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-004947

CVP, JAPAC sold 330 shares at $74.42 ($24,560)

  • CVP, JAPAC acquired 330 shares (option exercise)
  • CVP, JAPAC acquired 4,225 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, JAPAC

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-08 Grant or award : show line 1 in the form 10b5-1 +4,225 26,616.11 D
2025-05-09 Exercise or conversion : show line 2 in the form 10b5-1 +330 $45.28 $14,941 26,946.11 D
2025-05-09 Sale : show line 3 in the form 10b5-1 −330 $74.42 $24,560 26,616.11 D
Open-market sales · 330 sh · avg $74.42 · $24,560

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-05-08 Grant or award : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) +21,500 21,500 D
2025-05-08 Grant or award : show line 5 in the form 10b5-1 Performance Rights +4,225 4,225 D
2025-05-09 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (Right to Acquire) −330 0 D
Loading xslF345X05/doc4.xml…